MeshFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration sur la COVID en France - Exploration (Accueil)

Index « MeshFr.i » - entrée « Interactions médicamenteuses »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Interactions hôte-pathogène < Interactions médicamenteuses < Interface utilisateur  Facettes :

List of bibliographic references indexed by Interactions médicamenteuses

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000152 (2020) H. Javelot [France] ; P-M Llorca [France] ; D. Drapier [France] ; E. Fakra [France] ; C. Hingray [France] ; G. Meyer [France] ; S. Dizet [France] ; A. Egron [France] ; C. Straczek [France] ; M. Roser [France] ; M. Masson [France] ; R. Gaillard [France] ; P. Fossati [France] ; E. Haffen [France][Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
000180 (2020) A. Chevance [France] ; D. Gourion [France] ; N. Hoertel [France] ; P-M Llorca [France] ; P. Thomas [France] ; R. Bocher [France] ; M-R Moro [France] ; V. Laprévote [France] ; A. Benyamina [France] ; P. Fossati [France] ; M. Masson [France] ; E. Leaune [France] ; M. Leboyer [France] ; R. Gaillard [France][Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review].
000921 (2020) Nicolas Venisse [France]Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.
000922 (2020) Florian Lemaitre [France] ; Caroline Solas [France] ; Matthieu Grégoire [France] ; Laurence Lagarce [France] ; Laure Elens [Belgique] ; Elisabeth Polard [France] ; Béatrice Saint-Salvi [France] ; Agnès Sommet [France] ; Michel Tod [France] ; Chantal Barin-Le Guellec [France]Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.
000950 (2020) Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink [Pays-Bas] ; Stein Bergan [Norvège] ; Dirk Jan A R. Moes [Pays-Bas] ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France]Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.
001203 (2020) Roch Houot [États-Unis] ; Ronald Levy [États-Unis] ; Guillaume Cartron [France] ; Philippe Armand [États-Unis]Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
001276 (2020) Nicolas Venisse [France] ; Gilles Peytavin [France] ; Stephane Bouchet [France] ; Marie-Claude Gagnieu [France] ; Rodolphe Garraffo [France] ; Romain Guilhaumou [France] ; Caroline Solas [France]Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
001570 (2020) André Baruchel [France] ; Yves Bertrand [France] ; Nicolas Boissel [France] ; Benoit Brethon [France] ; Stéphane Ducassou [France] ; Virginie Gandemer [France] ; Carine Halfon-Domenech [France] ; Thierry Leblanc [France] ; Guy Leverger [France] ; Gérard Michel [France] ; Arnaud Petit [France] ; Anne-France Ray-Lunven [France] ; Pierre-Simon Rohrlich [France] ; Pascale Schneider [France] ; Nicolas Sirvent [France] ; Marion Strullu [France]COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE).
001695 (2020) Paul Gougis [France] ; Charlotte Fenioux [France] ; Christian Funck-Brentano [France] ; Marianne Veyri [France] ; Joseph Gligorov [France] ; Caroline Solas [France] ; Jean-Philippe Spano [France]Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?
001856 (2020) Jean-Louis Montastruc [France] ; Pierre-Louis Toutain [France, Royaume-Uni]A New Drug-Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Interactions médicamenteuses" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Interactions médicamenteuses" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Interactions médicamenteuses
}}
Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021